FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089750 [Registered on: 27/06/2025] Trial Registered Prospectively
Last Modified On: 24/06/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Single Arm Study 
Public Title of Study   Effect of Integrated Approach Along with Ayurvedic Formulation (Peedanil Gold) in Chronic Low Back Pain. 
Scientific Title of Study   Evaluating the Effect of Integrated Approach Along with Ayurvedic Formulation (Peedanil Gold) in Chronic Low Back Pain: Prospective, Open Label, Single Arm, Observational Study.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ajay Singh 
Designation  Associate Professor 
Affiliation  Patanjali Ayurveda Hospital 
Address  OPD No 31 Department of Panchkarma Patanjali Yogpeeth Maharshi Dayanand Gram Delhi Haridwar National Highway Near Bahadrabad Haridwar Uttarakhand

Hardwar
UTTARANCHAL
249405
India 
Phone  9039402300  
Fax    
Email  drajaysingh82@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ajay Singh 
Designation  Associate Professor 
Affiliation  Patanjali Ayurveda Hospital 
Address  OPD No 31 Department of Panchkarma Patanjali Yogpeeth Maharshi Dayanand Gram Delhi Haridwar National Highway Near Bahadrabad Haridwar Uttarakhand


UTTARANCHAL
249405
India 
Phone  9039402300  
Fax    
Email  drajaysingh82@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ajay Singh 
Designation  Associate Professor 
Affiliation  Patanjali Ayurveda Hospital 
Address  OPD No 31 Department of Panchkarma Patanjali Yogpeeth Maharshi Dayanand Gram Delhi Haridwar National Highway Near Bahadrabad Haridwar Uttarakhand


UTTARANCHAL
249405
India 
Phone  9039402300  
Fax    
Email  drajaysingh82@gmail.com  
 
Source of Monetary or Material Support  
Patanjali Research Foundation Governed by Patanjali Research Foundation Trust NH 58 Near Bahadrabad Haridwar Uttarakhand 249405 India  
 
Primary Sponsor  
Name  Patanjali Research Foundation  
Address  NH 58 Near Bahadrabad Haridwar Uttarakhand 249405 India 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 3  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ajay Singh  Patanjali Ayurveda Hospital  OPD No 31 Department of Panchkarma Patanjali Yogpeeth Maharshi Dayanand Gram Delhi Haridwar National Highway Near Bahadrabad Haridwar 249405 Uttarakhand India
Hardwar
UTTARANCHAL 
9039402300

drajaysingh82@gmail.com 
Dr Ajay Singh  Patanjali Wellness  OPD No 17 Department of Panchkarma Patanjali Wellness Delhi Haridwar National Highway Near Bahadrabad Haridwar 249405 Uttarakhand India
Hardwar
UTTARANCHAL 
9039402300

drajaysingh82@gmail.com 
Dr Ajay Singh  Patanjali Yoggram  OPD No 13 Department of Panchkarma Patanjali Yoggram Yog Naturopathy Panchkarma Treatment and Research Centre Yoggram Village Aurangabad Near SIDCUL Roshnabad Haridwar 249402 Uttarakhand India
Hardwar
UTTARANCHAL 
9039402300

drajaysingh82@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 3  
Name of Committee  Approval Status 
PATANJALI AYURVED COLLEGE ETHICS COMMITTEE  Approved 
PATANJALI AYURVED COLLEGE ETHICS COMMITTEE  Approved 
PATANJALI AYURVED COLLEGE ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M545||Low back pain. Ayurveda Condition: TRIKASULAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Subjects who had been experiencing chronic back pain that had been pre diagnosed for longer than three months.
Patients with acute musculoskeletal spasm with low back pain due to Lumbar spondylosis osteoarthritis Acute lumbosacral strain Blunt superficial trauma prolapsed intervertebral disc.
Patients who are ready to give written informed consent and comply with the protocol requirements.
 
 
ExclusionCriteria 
Details  Previous back surgery Diabetic and diagnosed with CLBP as a result of organic spine diseases, such as primary or secondary cancer chronic infections as identified by lumbar spine X rays chronic diseases like tuberculosis renal disease hemorrhagic sickness inflammatory low back pain and acute rheumatoid arthritis were not included in this study.
Patients with acute muscle spasms who need parenteral therapy surgery or hospital admissions for management.
Pregnant or lactating women.
Patients are unwilling or unable to comply with the study procedures.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Changes in the severity of pain by using Visual Analogue Scale and disability level of back pain by using The Oswestry Disability Index.  From Baseline to Day 7 Day 30 Day 60 and Day 90 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in the Quality of life by using WHOQOL-BREF  From Baseline to Day 7 Day 30 Day 60 and Day 90 
 
Target Sample Size   Total Sample Size="56"
Sample Size from India="56" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is a prospective, open-label, single-arm, observational study. Subjects will be screened on the basis of Inclusion/Exclusion criteria and enrolled after obtaining written Informed consent. After enrollment,  the investigator will plan 7 days Panchkarma procedure, yoga and naturopathy treatment along with oral medication Peedanil Gold. After 7 days the subject will be continue Peedanil Gold oral medication for next 3 months and  the severity of pain and quality of life will be assessed by using specfic questionnaire at Day 30, Day 60 and Day 90 interval..

 
Close